Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects
Comparative Evaluation of Treatment Of Infrabony Defects With and Without 1.2% Rosuvastatin Gel: In-Vivo Study
Sponsor: Dr. D. Y. Patil Dental College & Hospital
Listed as NCT03677297, this PHASE4 trial focuses on Adult Periodontitis and remains completed. Sponsored by Dr. D. Y. Patil Dental College & Hospital, it has been updated 4 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Oct 2018 — Jan 2021 [monthly]
Completed PHASE4
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dr. D. Y. Patil Dental College & Hospital
For direct contact, visit the study record on ClinicalTrials.gov .